Biden tests adverse for Covid-19 days absent from G20 summit

Biden tests adverse for Covid-19 days absent from G20 summit


U.S. President Joe Biden leaves next solutions at St. Edmond’s Catholic Church in Rehoboth Seashore, Delaware, September 3, 2023.

Amanda Andrade-Rhoades | Reuters

WASHINGTON — President Joe Biden tested detrimental Monday night time for Covid-19, a working day right after his wife examined positive and a few times just before he is scheduled to journey abroad.

Biden is damaging and not enduring any signs and symptoms, White Dwelling push secretary Karine Jean-Pierre claimed Tuesday.

First girl Jill Biden tested favourable on Monday night, but so much she has professional delicate symptoms, the White Property explained. The Bidens had been at their residence jointly in Rehoboth, Delaware, about Labor Working day weekend just after halting in Florida on Saturday to study hurt brought about by Hurricane Idalia. The president last observed the 1st lady on Monday morning right before he traveled to an function in Philadelphia.

The to start with lady will continue to be in Delaware for the relaxation of the week, Jean-Pierre stated.

The president is scheduled to depart for India on Thursday to go to the Team of 20 summit, and then go on to stop by Hanoi, Vietnam, on Sunday. On Monday, Biden will be in Alaska to observe the 22nd anniversary of the 9/11 attacks.

If Biden had been to examination favourable for Covid in the future handful of times, he could go to the G20 conferences just about, like his predecessor Donald Trump did in the course of the Covid pandemic.

If he were being forced to keep dwelling, the president could unintentionally locate himself in ignominious business. Russian President Vladimir Putin will not be attending the convention for the 2nd calendar year in a row, and Chinese President Xi Jinping also strategies to skip it.

“I am disappointed,” Biden reported of Xi’s absence, “but I am heading to get to see him.”



Resource

Merck shells out  billion for London-based lung therapy firm Verona
World

Merck shells out $10 billion for London-based lung therapy firm Verona

Bloomberg | Bloomberg | Getty Images Merck will buy UK-based Verona Pharma for about $10 billion, the companies said on Wednesday, strengthening the U.S. firm’s respiratory treatment portfolio in a bid to diversify its revenue source beyond blockbuster cancer drug. Merck has been leaning on its aging cancer immunotherapy Keytruda, the world’s top-selling prescription medicine, […]

Read More
Singapore state investor Temasek is rethinking defense as a strategic ESG bet
World

Singapore state investor Temasek is rethinking defense as a strategic ESG bet

Defense stocks are booming — and according to one of Asia’s biggest investors, allocating capital to the sector doesn’t mean having to abandon ESG initiatives. Speaking to CNBC’s Martin Soong on Wednesday, Rohit Sipahimalani, chief investment officer at Singapore’s state investment fund Temasek, said his team were looking at opportunities in the European defense sector. […]

Read More
Shares of Ray-Ban maker EssilorLuxottica jump 6% on reported Meta stake in AI push
World

Shares of Ray-Ban maker EssilorLuxottica jump 6% on reported Meta stake in AI push

Smart Ray-Ban Glasses, on June 16, 2024, in Caen, Normandy, France. Nurphoto | Getty Images Shares of Ray-Ban maker EssilorLuxottica almost 6% on Wednesday on reports that Meta has taken a minority stake in the company amid growing appetite for AI-powered wearable devices. Meta reportedly bought a stake worth around 3 billion euros ($3.51 billion) […]

Read More